MedTrace Logo

Comparison of Tesio and LifeCath Twin Permanent Dialysis Catheters

NCT01022359 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-04-22

Study results available
· View outcomes & findings →

Summary

This study aims to compare two available types of central venous haemodialysis catheters (lines) - CVCs, and will examine how easy they are to insert, complications, blood flow on dialysis over time, line loss, line clotting and infective events. It will examine whether the LifeCath type of CVC can deliver high blood flow rates from first use after insertion and equivalent function and complication rate to the Tesio type of CVC that is in use in our centre already. Complications relating to dialysis access make up 30% of admissions for haemodialysis patients and so this is a study that could benefit patients and their care providers.

Conditions

  • Hemodialysis

Interventions

DEVICE

TesioCath

Insertion of the TesioCath(TM) central venous catheter for haemodialysis vascular access

DEVICE

LifeCath Twin

Insertion of the LifeCath Twin central venous catheter for haemodialysis vascular access

Sponsors & Collaborators

  • Imperial College Healthcare NHS Trust

    lead OTHER

Principal Investigators

  • Neill Duncan, MBBS MRCP · Imperial College Healthcare NHS Trust

  • Albert Power, MBBChir MRCP · Imperial College Healthcare NHS Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-07-31
Completion
2011-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01022359 on ClinicalTrials.gov